Palvella Therapeutics Appoints New Board Member

Palvella Therapeutics has appointed Dr. John D. Doux, a dermatologist and recognized leader in rare skin diseases, to its Board of Directors. Dr. Doux brings over two decades of experience in clinical practice, biotechnology investing, and board governance. His expertise is expected to provide valuable strategic guidance to Palvella Therapeutics as it advances its development programs. This appointment strengthens the company's leadership team with significant industry knowledge.